152 related articles for article (PubMed ID: 20688085)
1. Cox-2 inhibition attenuates cardiovascular and inflammatory aspects in monosodium glutamate-induced obese rats.
Cunha NV; de Abreu SB; Panis C; Grassiolli S; Guarnier FA; Cecchini R; Mazzuco TL; Pinge-Filho P; Martins-Pinge MC
Life Sci; 2010 Sep; 87(11-12):375-81. PubMed ID: 20688085
[TBL] [Abstract][Full Text] [Related]
2. COX-2 inhibition does not reverse the increased sympathetic modulation in MSG obese rats.
da Cunha NV; Pinge-Filho P; Barbosa Neto O; Grassiolli S; Martins-Pinge MC
Auton Neurosci; 2011 Dec; 165(2):201-4. PubMed ID: 21824825
[TBL] [Abstract][Full Text] [Related]
3. iNOS inhibition improves autonomic dysfunction and oxidative status in hypertensive obese rats.
da Cunha NV; Lopes FN; Panis C; Cecchini R; Pinge-Filho P; Martins-Pinge MC
Clin Exp Hypertens; 2017; 39(1):50-57. PubMed ID: 28055264
[TBL] [Abstract][Full Text] [Related]
4. Renal functional responses to ischaemia-reperfusion injury in normotensive and hypertensive rats following non-selective and selective cyclo-oxygenase inhibition with nitric oxide donation.
Knight S; Johns EJ
Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):11-6. PubMed ID: 18047621
[TBL] [Abstract][Full Text] [Related]
5. Altered baroreflex and autonomic modulation in monosodium glutamate-induced hyperadipose rats.
Karlen-Amarante M; da Cunha NV; de Andrade O; de Souza HC; Martins-Pinge MC
Metabolism; 2012 Oct; 61(10):1435-42. PubMed ID: 22554831
[TBL] [Abstract][Full Text] [Related]
6. Decreased endothelial nitric oxide, systemic oxidative stress, and increased sympathetic modulation contribute to hypertension in obese rats.
da Cunha NV; Pinge-Filho P; Panis C; Silva BR; Pernomian L; Grando MD; Cecchini R; Bendhack LM; Martins-Pinge MC
Am J Physiol Heart Circ Physiol; 2014 May; 306(10):H1472-80. PubMed ID: 24633548
[TBL] [Abstract][Full Text] [Related]
7. Renal sympathetic nerve activity is increased in monosodium glutamate induced hyperadipose rats.
da Silva Mattos AM; Xavier CH; Karlen-Amarante M; da Cunha NV; Fontes MA; Martins-Pinge MC
Neurosci Lett; 2012 Aug; 522(2):118-22. PubMed ID: 22705582
[TBL] [Abstract][Full Text] [Related]
8. Celecoxib attenuates liver steatosis and inflammation in non-alcoholic steatohepatitis induced by high-fat diet in rats.
Chen J; Liu D; Bai Q; Song J; Guan J; Gao J; Liu B; Ma X; Du Y
Mol Med Rep; 2011; 4(5):811-6. PubMed ID: 21643627
[TBL] [Abstract][Full Text] [Related]
9. Obesity induced by neonatal treatment with monosodium glutamate impairs microvascular reactivity in adult rats: role of NO and prostanoids.
Lobato NS; Filgueira FP; Akamine EH; Davel AP; Rossoni LV; Tostes RC; Carvalho MH; Fortes ZB
Nutr Metab Cardiovasc Dis; 2011 Oct; 21(10):808-16. PubMed ID: 20554176
[TBL] [Abstract][Full Text] [Related]
10. COX-2-mediated inflammation in fat is crucial for obesity-linked insulin resistance and fatty liver.
Hsieh PS; Jin JS; Chiang CF; Chan PC; Chen CH; Shih KC
Obesity (Silver Spring); 2009 Jun; 17(6):1150-7. PubMed ID: 19247274
[TBL] [Abstract][Full Text] [Related]
11. More pronounced inhibition of cyclooxygenase 2, increase in blood pressure, and reduction of heart rate by treatment with diclofenac compared with celecoxib and rofecoxib.
Hinz B; Dormann H; Brune K
Arthritis Rheum; 2006 Jan; 54(1):282-91. PubMed ID: 16385545
[TBL] [Abstract][Full Text] [Related]
12. Improvement of metabolic parameters and vascular function by metformin in obese non-diabetic rats.
Lobato NS; Filgueira FP; Hagihara GN; Akamine EH; Pariz JR; Tostes RC; Carvalho MH; Fortes ZB
Life Sci; 2012 Jan; 90(5-6):228-35. PubMed ID: 22154980
[TBL] [Abstract][Full Text] [Related]
13. Effect of celecoxib on the antihypertensive effect of losartan in a rat model of renovascular hypertension.
Boshra V; El Wakeel GA; Nader MA
Can J Physiol Pharmacol; 2011 Feb; 89(2):103-7. PubMed ID: 21326341
[TBL] [Abstract][Full Text] [Related]
14. Monosodium glutamate neonatal intoxication associated with obesity in adult stage is characterized by chronic inflammation and increased mRNA expression of peroxisome proliferator-activated receptors in mice.
Roman-Ramos R; Almanza-Perez JC; Garcia-Macedo R; Blancas-Flores G; Fortis-Barrera A; Jasso EI; Garcia-Lorenzana M; Campos-Sepulveda AE; Cruz M; Alarcon-Aguilar FJ
Basic Clin Pharmacol Toxicol; 2011 Jun; 108(6):406-13. PubMed ID: 21205225
[TBL] [Abstract][Full Text] [Related]
15. Effects of bezafibrate in nonalcoholic steatohepatitis model mice with monosodium glutamate-induced metabolic syndrome.
Sasaki Y; Shimada T; Iizuka S; Suzuki W; Makihara H; Teraoka R; Tsuneyama K; Hokao R; Aburada M
Eur J Pharmacol; 2011 Jul; 662(1-3):1-8. PubMed ID: 21549692
[TBL] [Abstract][Full Text] [Related]
16. Effect of fasting and refeeding on duodenal alkaline phosphatase activity in monosodium glutamate obese rats.
Racek L; Lenhardt L; Mozes S
Physiol Res; 2001; 50(4):365-72. PubMed ID: 11551142
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of selective cyclooxygenase-2 inhibitors on endothelial function in salt-induced hypertension.
Hermann M; Camici G; Fratton A; Hurlimann D; Tanner FC; Hellermann JP; Fiedler M; Thiery J; Neidhart M; Gay RE; Gay S; Lüscher TF; Ruschitzka F
Circulation; 2003 Nov; 108(19):2308-11. PubMed ID: 14597594
[TBL] [Abstract][Full Text] [Related]
18. Selective cyclo-oxygenase-2 inhibition with celecoxib elevates blood pressure and promotes leukocyte adherence.
Muscará MN; Vergnolle N; Lovren F; Triggle CR; Elliott SN; Asfaha S; Wallace JL
Br J Pharmacol; 2000 Apr; 129(7):1423-30. PubMed ID: 10742298
[TBL] [Abstract][Full Text] [Related]
19. Inducible cyclooxygenase expression mediating hypoxia/reoxygenation-induced pulmonary vasoconstriction is attenuated by a cyclooxygenase inhibitor in rats.
Su CL; Yuan DW; Chiang LL; Lee HL; Chen KH; Wang D
Transplant Proc; 2012 May; 44(4):929-32. PubMed ID: 22564588
[TBL] [Abstract][Full Text] [Related]
20. Decreased lipolysis and enhanced glycerol and glucose utilization by adipose tissue prior to development of obesity in monosodium glutamate (MSG) treated-rats.
Dolnikoff M; Martín-Hidalgo A; Machado UF; Lima FB; Herrera E
Int J Obes Relat Metab Disord; 2001 Mar; 25(3):426-33. PubMed ID: 11319642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
